Men’s Health Advisor - Label change ordered for prostate drug
Sunday, January 4th, 2009The U.S. Food and Drug Administration (FDA) has ordered the makers of Flomax, the most commonly prescribed drug to treat benign prostatic hyperplasia (enlarged prostate), to change the label to reflect the possibility that the drug is linked to a condition that can complicate cataract surgery. Enlarged-prost…
